LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article ; Online: Veno-venous extracorporeal membrane oxygenation for severe pneumonia: COVID-19 case in Japan.

    Taniguchi, Hayato / Ogawa, Fumihiro / Honzawa, Hiroshi / Yamaguchi, Keishi / Niida, Shoko / Shinohara, Mafumi / Takahashi, Kohei / Iwashita, Masayuki / Abe, Takeru / Kubo, Sousuke / Kudo, Makoto / Takeuchi, Ichiro

    Acute medicine & surgery

    2020  Volume 7, Issue 1, Page(s) e509

    Abstract: Background: Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is one of the ultimate ... off ECMO on day 12.: Conclusion: Treatment of severe pneumonia in COVID-19 by ECMO should recognize ... coronavirus disease (COVID-19) is unknown.: Case presentation: A 72-year-old woman who was a passenger ...

    Abstract Background: Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is one of the ultimate treatments for acute respiratory failure. However, the effectiveness of ECMO in patients with novel coronavirus disease (COVID-19) is unknown.
    Case presentation: A 72-year-old woman who was a passenger of a cruise ship tested positive for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) while in quarantine on board using throat swab. Three days after admission, her condition deteriorated, and she was subsequently intubated. On day 6, VV-ECMO was introduced. Lopinavir/ritonavir was given; continuous renal replacement therapy was also introduced. On day 10, her chest radiography and lung compliance improved. She was weaned off ECMO on day 12.
    Conclusion: Treatment of severe pneumonia in COVID-19 by ECMO should recognize lung plasticity considering time to ECMO introduction and interstitial biomarkers. In Japan, centralization of ECMO patients has not been sufficient. Thus, we suggest nationwide centralization and further research to respond to the crisis caused by COVID-19.
    Keywords covid19
    Language English
    Publishing date 2020-04-14
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2751184-4
    ISSN 2052-8817 ; 2052-8817
    ISSN (online) 2052-8817
    ISSN 2052-8817
    DOI 10.1002/ams2.509
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article: Veno-venous extracorporeal membrane oxygenation for severe pneumonia: COVID-19 case in Japan

    Taniguchi, Hayato / Ogawa, Fumihiro / Honzawa, Hiroshi / Yamaguchi, Keishi / Niida, Shoko / Shinohara, Mafumi / Takahashi, Kohei / Iwashita, Masayuki / Abe, Takeru / Kubo, Sousuke / Kudo, Makoto / Takeuchi, Ichiro

    Acute Med. Surg.

    Abstract: Background: Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is one of the ultimate ... off ECMO on day 12. Conclusion: Treatment of severe pneumonia in COVID-19 by ECMO should recognize ... coronavirus disease (COVID-19) is unknown. Case Presentation: A 72-year-old woman who was a passenger ...

    Abstract Background: Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is one of the ultimate treatments for acute respiratory failure. However, the effectiveness of ECMO in patients with novel coronavirus disease (COVID-19) is unknown. Case Presentation: A 72-year-old woman who was a passenger of a cruise ship tested positive for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) while in quarantine on board using throat swab. Three days after admission, her condition deteriorated, and she was subsequently intubated. On day 6, VV-ECMO was introduced. Lopinavir/ritonavir was given; continuous renal replacement therapy was also introduced. On day 10, her chest radiography and lung compliance improved. She was weaned off ECMO on day 12. Conclusion: Treatment of severe pneumonia in COVID-19 by ECMO should recognize lung plasticity considering time to ECMO introduction and interstitial biomarkers. In Japan, centralization of ECMO patients has not been sufficient. Thus, we suggest nationwide centralization and further research to respond to the crisis caused by COVID-19.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #102563
    Database COVID19

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  3. Article ; Online: Veno‐venous extracorporeal membrane oxygenation for severe pneumonia

    Taniguchi, Hayato / Ogawa, Fumihiro / Honzawa, Hiroshi / Yamaguchi, Keishi / Niida, Shoko / Shinohara, Mafumi / Takahashi, Kohei / Iwashita, Masayuki / Abe, Takeru / Kubo, Sousuke / Kudo, Makoto / Takeuchi, Ichiro

    Acute Medicine & Surgery

    COVID‐19 case in Japan

    2020  Volume 7, Issue 1

    Keywords covid19
    Language English
    Publisher Wiley
    Publishing country us
    Document type Article ; Online
    ISSN 2052-8817
    DOI 10.1002/ams2.509
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  4. Article ; Online: Veno‐venous extracorporeal membrane oxygenation for severe pneumonia

    Taniguchi, Hayato / Ogawa, Fumihiro / Honzawa, Hiroshi / Yamaguchi, Keishi / Niida, Shoko / Shinohara, Mafumi / Takahashi, Kohei / Iwashita, Masayuki / Abe, Takeru / Kubo, Sousuke / Kudo, Makoto / Takeuchi, Ichiro

    Acute medicine & surgery, 7(1):e509

    COVID‐19 case in Japan

    2020  

    Abstract: BACKGROUND: Veno‐venous extracorporeal membrane oxygenation (VV‐ECMO) is one of the ultimate ... off ECMO on day 12. CONCLUSION: Treatment of severe pneumonia in COVID‐19 by ECMO should recognize ... coronavirus disease (COVID‐19) is unknown. CASE PRESENTATION: A 72‐year‐old woman who was a passenger ...

    Abstract BACKGROUND: Veno‐venous extracorporeal membrane oxygenation (VV‐ECMO) is one of the ultimate treatments for acute respiratory failure. However, the effectiveness of ECMO in patients with novel coronavirus disease (COVID‐19) is unknown. CASE PRESENTATION: A 72‐year‐old woman who was a passenger of a cruise ship tested positive for the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) while in quarantine on board using throat swab. Three days after admission, her condition deteriorated, and she was subsequently intubated. On day 6, VV‐ECMO was introduced. Lopinavir/ritonavir was given; continuous renal replacement therapy was also introduced. On day 10, her chest radiography and lung compliance improved. She was weaned off ECMO on day 12. CONCLUSION: Treatment of severe pneumonia in COVID‐19 by ECMO should recognize lung plasticity considering time to ECMO introduction and interstitial biomarkers. In Japan, centralization of ECMO patients has not been sufficient. Thus, we suggest nationwide centralization and further research to respond to the crisis caused by COVID‐19.
    Keywords Coronavirus disease 2019 ; COVID-19 ; Japan ; lopinavir ; severe acute respiratorysyndrome coronavirus 2 ; extracorporeal membrane oxygenation ; Coronavirus ; ritonavir ; covid19
    Language English
    Publishing country de
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  5. Article ; Online: Pancreatitis in a Patient with Severe Coronavirus Disease Pneumonia Treated with Veno-venous Extracorporeal Membrane Oxygenation.

    Kurihara, Yutaro / Maruhashi, Takaaki / Wada, Tatsuhiko / Osada, Mayuko / Oi, Marina / Yamaoka, Kunihiro / Asari, Yasushi

    Internal medicine (Tokyo, Japan)

    2020  Volume 59, Issue 22, Page(s) 2903–2906

    Abstract: ... with severe COVID-19 pneumonia and was successfully treated with veno-venous ... of acute pancreatitis due to COVID-19. Although we found that severe COVID-19 pneumonia can lead ... extracorporeal membrane oxygenation (ECMO). Elevated pancreatic enzymes levels and computed tomography findings led to the diagnosis ...

    Abstract Severe coronavirus disease (COVID-19) can induce serious complications, including acute respiratory distress syndrome, septic shock, and acute kidney injury. However, few reports have associated COVID-19 with pancreatitis. We herein report the case of a 55-year-old patient who developed acute pancreatitis associated with severe COVID-19 pneumonia and was successfully treated with veno-venous extracorporeal membrane oxygenation (ECMO). Elevated pancreatic enzymes levels and computed tomography findings led to the diagnosis of acute pancreatitis due to COVID-19. Although we found that severe COVID-19 pneumonia can lead to pancreatitis, the underlying pathophysiology remains unknown.
    MeSH term(s) Acute Disease ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/complications ; Coronavirus Infections/epidemiology ; Coronavirus Infections/therapy ; Extracorporeal Membrane Oxygenation/methods ; Humans ; Male ; Middle Aged ; Pancreatitis/diagnosis ; Pancreatitis/etiology ; Pancreatitis/therapy ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/therapy ; SARS-CoV-2 ; Tomography, X-Ray Computed/methods
    Keywords covid19
    Language English
    Publishing date 2020-09-19
    Publishing country Japan
    Document type Case Reports ; Journal Article
    ZDB-ID 32371-8
    ISSN 1349-7235 ; 0021-5120 ; 0918-2918
    ISSN (online) 1349-7235
    ISSN 0021-5120 ; 0918-2918
    DOI 10.2169/internalmedicine.5912-20
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 240: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  6. Article: Veno‐venous extracorporeal membrane oxygenation for severe pneumonia: COVID‐19 case in Japan

    Taniguchi, Hayato / Ogawa, Fumihiro / Takahashi, Kohei

    Acute medicine & surgery, 7(1):e509

    2020  

    Abstract: BACKGROUND: Veno‐venous extracorporeal membrane oxygenation (VV‐ECMO) is one of the ultimate ... off ECMO on day 12. CONCLUSION: Treatment of severe pneumonia in COVID‐19 by ECMO should recognize ... coronavirus disease (COVID‐19) is unknown. CASE PRESENTATION: A 72‐year‐old woman who was a passenger ...

    Abstract BACKGROUND: Veno‐venous extracorporeal membrane oxygenation (VV‐ECMO) is one of the ultimate treatments for acute respiratory failure. However, the effectiveness of ECMO in patients with novel coronavirus disease (COVID‐19) is unknown. CASE PRESENTATION: A 72‐year‐old woman who was a passenger of a cruise ship tested positive for the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) while in quarantine on board using throat swab. Three days after admission, her condition deteriorated, and she was subsequently intubated. On day 6, VV‐ECMO was introduced. Lopinavir/ritonavir was given; continuous renal replacement therapy was also introduced. On day 10, her chest radiography and lung compliance improved. She was weaned off ECMO on day 12. CONCLUSION: Treatment of severe pneumonia in COVID‐19 by ECMO should recognize lung plasticity considering time to ECMO introduction and interstitial biomarkers. In Japan, centralization of ECMO patients has not been sufficient. Thus, we suggest nationwide centralization and further research to respond to the crisis caused by COVID‐19.
    Keywords COVID-19 ; Coronavirus ; Coronavirus disease 2019 ; Japan ; extracorporeal membrane oxygenation ; lopinavir ; severe acute respiratorysyndrome coronavirus 2 ; ritonavir
    Language English
    Document type Article
    Database Repository for Life Sciences

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top